Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-29 @ 11:37 PM
Study NCT ID:
NCT00366704
Status:
TERMINATED
Last Update Posted:
2013-02-11
First Post:
2006-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3168A1-313
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Wyeth (Registry Contact: Clinical Trial Registry Specialist)
Old Organization:
Wyeth
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |